ribavirin has been researched along with Renal Insufficiency in 20 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 6 (30.00) | 29.6817 |
2010's | 14 (70.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arakawa, T; Hige, S; Karino, T; Kimura, M; Kuwata, Y; Nakajima, T; Ohmura, T; Ozeki, I; Sato, T; Toyota, J | 1 |
Blotner, S; Brennan, BJ; Grippo, JF; Magnusson, MO; Martin, P; Nieforth, K; Solsky, J; Wang, K; Wat, C; Wilkins, JJ | 1 |
Galati, G; Gallo, P; Menna, P; Minotti, G; Picardi, A; Salvatorelli, E; Vespasiani Gentilucci, U | 1 |
Arotçarena, R; Causse, X; Denis, J; Hagège, H; Henrion, J; Lesgourgues, B; Nalet, B; Pariente, A; Rémy, AJ | 1 |
Arizumi, T; Chishina, H; Hagiwara, S; Inoue, T; Kitai, S; Kouno, M; Kudo, M; Minami, Y; Takita, M; Ueshima, K; Yada, N | 1 |
Aboulker, JP; Barrail-Tran, A; Chevaliez, S; Cotte, L; Fournier, I; Lacombe, K; Molina, JM; Taburet, AM; Valantin, MA; Vincent, C | 1 |
Dybowska, D; Karwowska, K; Kozielewicz, D; Wietlicka-Piszcz, M | 1 |
Kattakuzhy, S; Kottilil, S; Tang, L; Ward, H; Wilson, E | 1 |
Craft, ZN; Kamal, KM; Koerner, PH; Miller, RT; Trombatt, WD | 1 |
Badri, PS; Eckert, D; Menon, RM; Mensing, S; Polepally, AR | 1 |
Lange, CM; Mücke, MM; Mücke, VT; Zeuzem, S | 1 |
Dixit, V; Fabrizi, F; Martin, P; Messa, P | 1 |
Albrecht, JK; Bloomer, JR; Boparai, N; Brass, CA; Brown, KA; Galler, GW; Ghalib, RH; Herrine, SK; Jiang, R; King, JW; McCone, J; McHutchison, JG; Melia, MT; Muir, AJ; Mullen, KD; Noviello, S; Nunes, FA; Ravendhran, N; Shiffman, ML; Sulkowski, MS | 1 |
Bessede, T; Buffet, C; Charpentier, B; Durrbach, A; Hassan, Q; Roche, B; Samuel, D | 1 |
Carenzi, S; Ciancio, A; Olivero, A; Rizzetto, M; Saracco, G | 1 |
Bruchfeld, A; Lindahl, K; Schvarcz, R; Söderberg, M; Ståhle, L | 1 |
Anaissie, EJ; Aslan, T; Barlogie, B; Desikan, R; Fassas, A; Mahfouz, TH; Pouli, A | 1 |
Brouwer, JT; Mathot, RA; Orlent, H; Schalm, SW; Van Bommel, EF; Vulto, AG | 1 |
Alric, L; Kamar, N; Rostaing, L | 1 |
Carriero, D; Dieterich, DT; Fabrizi, F; Martin, P; Park, J; Uriel, AJ | 1 |
6 review(s) available for ribavirin and Renal Insufficiency
Article | Year |
---|---|
Dual sofosbuvir and ribavirin therapy for chronic hepatitis C infection.
Topics: Antiviral Agents; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Drug Resistance, Viral; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Liver Cirrhosis; Liver Failure; Liver Transplantation; Recurrence; Renal Insufficiency; Ribavirin; Sofosbuvir | 2016 |
Effects of Mild and Moderate Renal Impairment on Ombitasvir, Paritaprevir, Ritonavir, Dasabuvir, and Ribavirin Pharmacokinetics in Patients with Chronic HCV Infection.
Topics: 2-Naphthylamine; Adolescent; Adult; Aged; Anilides; Antiviral Agents; Area Under Curve; Carbamates; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Cyclopropanes; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Kidney Function Tests; Lactams, Macrocyclic; Macrocyclic Compounds; Male; Middle Aged; Models, Biological; Proline; Renal Insufficiency; Ribavirin; Ritonavir; Sulfonamides; Uracil; Valine; Young Adult | 2017 |
Special populations: treating hepatitis C in patients with decompensated cirrhosis and/or advanced renal impairment.
Topics: Antiviral Agents; Drug Therapy, Combination; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver Cirrhosis; Randomized Controlled Trials as Topic; Renal Insufficiency; Ribavirin; Sofosbuvir; Sustained Virologic Response | 2017 |
Combined antiviral therapy of hepatitis C virus in dialysis patients: meta-analysis of clinical trials.
Topics: Adult; Aged; Anemia; Antiviral Agents; Clinical Trials as Topic; Cohort Studies; Drug Therapy, Combination; Female; Heart Failure; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Interferon-beta; Interferons; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Renal Dialysis; Renal Insufficiency; Ribavirin; Treatment Outcome | 2011 |
Therapy of chronic hepatitis C: a critical review.
Topics: Age Factors; Alanine Transaminase; Animals; Blood Coagulation Disorders, Inherited; Depressive Disorder; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Genotype; Hepatitis C, Chronic; Humans; Interferon-alpha; Pregnancy; Recurrence; Renal Insufficiency; Ribavirin; Treatment Outcome | 2003 |
Treatment of hepatitis C-virus-related glomerulonephritis.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antiviral Agents; Cryoglobulinemia; Drug Therapy, Combination; Glomerulonephritis, Membranoproliferative; Hepatitis C; Humans; Immunosuppressive Agents; Interferon-alpha; Proteinuria; Renal Insufficiency; Renin-Angiotensin System; Ribavirin; Rituximab | 2006 |
3 trial(s) available for ribavirin and Renal Insufficiency
Article | Year |
---|---|
Safety, tolerability, and pharmacokinetics of ribavirin in hepatitis C virus-infected patients with various degrees of renal impairment.
Topics: Adult; Aged; Antiviral Agents; Area Under Curve; Drug Administration Schedule; Drug Dosage Calculations; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Metabolic Clearance Rate; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Renal Insufficiency; Ribavirin; Severity of Illness Index | 2013 |
Telaprevir enhances ribavirin-induced anaemia through renal function impairment.
Topics: Anemia; Antiviral Agents; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Hepatitis C, Chronic; HIV Infections; Humans; Interferon-alpha; Kidney; Male; Middle Aged; Oligopeptides; Polyethylene Glycols; Recombinant Proteins; Renal Insufficiency; Ribavirin | 2015 |
Treatment of dialysis patients with chronic hepatitis C using pegylated interferon and low-dose ribavirin.
Topics: Adult; Aged; Anti-Retroviral Agents; Antiviral Agents; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Patient Dropouts; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Recurrence; Renal Dialysis; Renal Insufficiency; Ribavirin; RNA, Viral; Time Factors; Treatment Outcome; Viral Load | 2008 |
11 other study(ies) available for ribavirin and Renal Insufficiency
Article | Year |
---|---|
Telaprevir impairs renal function and increases blood ribavirin concentration during telaprevir/pegylated interferon/ribavirin therapy for chronic hepatitis C.
Topics: Adult; Aged; Anemia; Antiviral Agents; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Oligopeptides; Renal Insufficiency; Ribavirin; Serum | 2014 |
Telaprevir raises the plasma/whole blood ribavirin ratio: trying to come full circle on a dangerous relationship.
Topics: Antiviral Agents; Female; Hepatitis C, Chronic; Humans; Male; Oligopeptides; Renal Insufficiency; Ribavirin | 2014 |
Renal dysfunction associated with telaprevir-containing triple therapy for chronic hepatitis C: is early prediction possible?
Topics: Adult; Aged; Anemia; Antiviral Agents; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Hemoglobins; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Oligopeptides; Predictive Value of Tests; Prospective Studies; Renal Insufficiency; Retrospective Studies; Ribavirin; Risk Factors | 2014 |
Efficacy and safety of telaprevir-based antiviral treatment for elderly patients with hepatitis C virus.
Topics: Adult; Aged; Anemia; Antiviral Agents; Biomarkers; Drug Eruptions; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Incidence; Interferon-alpha; Male; Middle Aged; Oligopeptides; Renal Insufficiency; Ribavirin; Time Factors; Treatment Outcome; Viral Load | 2014 |
Renal impairment in patients with chronic hepatitis C treated with first generation protease inhibitors.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Drug Therapy, Combination; Female; Hemoglobins; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Oligopeptides; Polyethylene Glycols; Proline; Recombinant Proteins; Renal Insufficiency; Retrospective Studies; Ribavirin; Risk Factors; Time Factors; Young Adult | 2015 |
Retrospective Analysis of the Medication Utilization and Clinical Outcomes of Patients Treated with Various Regimens for Hepatitis C Infection.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Cohort Studies; Drug Therapy, Combination; Drug Utilization; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Nausea; Polyethylene Glycols; Recombinant Proteins; Renal Insufficiency; Retrospective Studies; Ribavirin; Simeprevir; Sofosbuvir; Treatment Outcome; Young Adult | 2017 |
Racial differences in hepatitis C treatment eligibility.
Topics: Adult; Alcoholism; Antiviral Agents; Black People; Diabetes Complications; Eligibility Determination; Female; Heart Diseases; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Male; Mass Screening; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Renal Insufficiency; Retrospective Studies; Ribavirin; Substance-Related Disorders; Treatment Outcome; United States; White People | 2011 |
Liver-kidney recipients with chronic viral hepatitis C treated with interferon-alpha.
Topics: Acute Disease; Adult; Aged; Biopsy; Female; Graft Rejection; Hepatitis C; Humans; Immunosuppressive Agents; Interferon-alpha; Kidney Transplantation; Liver; Liver Failure; Liver Transplantation; Male; Middle Aged; Recurrence; Renal Insufficiency; Retrospective Studies; Ribavirin; Steroids; Transaminases; Treatment Outcome | 2012 |
Interferon and ribavirin treatment in patients with hepatitis C-associated renal disease and renal insufficiency.
Topics: Aged; Antiviral Agents; Chromatography, High Pressure Liquid; Creatinine; Female; Glomerulonephritis; Hepacivirus; Hepatitis C; Humans; Interferons; Kidney Diseases; Male; Middle Aged; Renal Insufficiency; Retrospective Studies; Ribavirin; RNA, Viral; Vasculitis | 2003 |
The natural history of respiratory syncytial virus infection in cancer and transplant patients: implications for management.
Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; Body Fluids; Female; Humans; Immunoglobulins, Intravenous; L-Lactate Dehydrogenase; Male; Middle Aged; Multiple Myeloma; Multivariate Analysis; Neoplasms; Peripheral Blood Stem Cell Transplantation; Renal Insufficiency; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Ribavirin; Time Factors | 2004 |
Peginterferon and dose-titrated ribavirin for hepatitis C-associated nephrotic membranoproliferative glomerulonephritis type 1.
Topics: Antiviral Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Glomerulonephritis, Membranoproliferative; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Middle Aged; Nephrotic Syndrome; Polyethylene Glycols; Recombinant Proteins; Renal Insufficiency; Ribavirin | 2005 |